Rankings
▼
Calendar
PBYI FY 2023 Earnings — Puma Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena
PBYI
Puma Biotechnology, Inc.
$311M
FY 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$236M
+3.3% YoY
Gross Profit
$173M
73.4% margin
Operating Income
$33M
13.9% margin
Net Income
$22M
9.2% margin
EPS (Diluted)
$0.45
Cash Flow
Operating Cash Flow
$27M
Free Cash Flow
$14M
Stock-Based Comp.
$10M
Balance Sheet
Total Assets
$231M
Total Liabilities
$177M
Stockholders' Equity
$53M
Cash & Equivalents
$85M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$236M
$228M
+3.3%
Gross Profit
$173M
$173M
+0.0%
Operating Income
$33M
$24M
+37.6%
Net Income
$22M
$2,000
+1079450.0%
← Q4 2022
All Quarters
Q1 2023 →